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Abstract
Idiopathic fibrosing pancreatitis has been associated with Sjo¨gren’s syndrome, primary biliary cirrhosis and primary
sclerosing cholangitis. This condition frequently develops in childhood and youth, and has also been related to ulcerative
colitis and pericholangitis. Pancreatic complications have been rarely described as systemic complications of ulcerative
colitis. A 25-year-old man presented with epigastric pain and jaundice. Abdominal ultrasonography, computed tomography
(CT), magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography
(ERCP) revealed a diffuse enlargement of the pancreas, filiform distal stenosis of the common bile duct and intrahepatic bile
ducts, and pancreatic duct dilatation. At operation, a rock-hard and nodular pancreas was noted. Cholecystectomy and
Roux-en-Y hepaticojejunostomy, with an access loop, was successfully performed. Idiopathic fibrosing pancreatitis should
be considered in young patients with obstructive jaundice, especially those affected with chronic inflammatory or
autoimmune diseases. Glucocorticoid therapy would be the first-line treatment, although many patients require operation.
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Introduction
Extra-colonic complications of ulcerative colitis can
involve many organs, including liver, biliary tract,
joints, eyes and skin. We present a case of obstructive
jaundice secondary to a fibrosing pancreatitis asso-
ciated with ulcerative colitis; complete symptomatic
recovery followed surgical treatment.
Case report
A 25-year-old man was admitted with epigastric pain
and jaundice. He had a 4-year history of ulcera-
tive colitis demonstrated by colonic biopsy. Acute
attacks of colitis had been treated with 5-aminosali-
cylate. There was no family history of pancreatic
disease, hepatic disorders or inflammatory intestinal
disease. Laboratory data revealed a total bilirubin
of 195 mmol/L (normalB/18), an alkaline phosphatase
of 1010 U/L (normalB/129), a gamma-glutamyl
transpeptidase of 214 U/L (normalB/61), SGOT of
184 U/L (normalB/37) and SGPT of 502 U/L
(normalB/40). Hepatitis serology was negative. IgG
levels were normal.
Ultrasonography revealed dilatation of the main bile
duct and pancreatic duct. An ill-defined nodule was
seen at the pancreatic head. Abdominal CT revealed
intrahepatic and extrahepatic dilatation of the upper
biliary tract, plus pancreatic duct dilatation and a
homogeneous enlargement of the head of pancreas
(Figure 1). The patient underwent endoscopic retro-
grade cholangiopancreatography (ERCP) (Figure 2)
and magnetic resonance cholangiopancreatography
(MRCP) (Figure 3), which revealed a filiform distal
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stenosis of the common bile duct with intrahepatic and
extrahepatic biliary tract dilatation.
Preoperative diagnoses were a focal inflammatory
process in the pancreas or sclerosing cholangitis. At
laparotomy, a rock-hard and nodular pancreas was
noted. Fine-needle aspiration biopsy of the pancreatic
head was combined with peripancreatic node biopsy,
bile cytology and choledochal brushings. Cholecys-
tectomy and Roux-en-Y hepaticojejunostomy with an
access loop were performed.
The histopathological report revealed a chronic
pancreatitis with lymphoplasmacytic infiltration; the
bile cytology and choledochal brushings were negative
for malignant cells.
The patient is well without signs of recurrence 2
years postoperatively.
Discussion
Sarles et al. described the concept of an autoimmune
aetiology in certain cases of chronic pancreatitis in
1961 [1]. In 1995, Yoshida et al. proposed that diseases
with the following characteristics be referred to as’au-
toimmune pancreatitis’: (1) increased serum gamma-
globulin or IgG levels; (2) presence of auto-antibodies;
(3) diffuse enlargement of the pancreas; (4) diffuse
irregular narrowing of the main pancreatic duct on
Figure 3. Magnetic resonance cholangiopancreatectomy (MRCP)
showing distended gallbladder. There is intrahepatic and extra-
hepatic dilatation and distal stenosis of the common bile duct.
Figure 1. Abdominal CT. Intrahepatic and extrahepatic dilatation of the upper biliary tract. Pancreatic duct dilatation and homogeneous
enlargement of the head of the pancreas are shown. No gallbladder stones were observed.
Figure 2. Endoscopic retrograde cholangiopancreatography
(ERCP). Filiform distal stenosis of the common bile duct. There
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ERCP; (5) fibrotic change with histopatho-logic lym-
phocytic infiltration; (6) absence of symptoms or only
mild symptoms, usually with an absence of acute
attacks of pancreatitis; (7) constriction of the common
bile duct in the pancreas with proximal dilatation, and
frequent cholestasis and hyperbilirubinaemia; (8) no
pancreatic calcification; (9) no pancreatic cysts; (10)
occasional association with other autoimmune dis-
eases; and (11) effectiveness of steroid therapy [2].
This condition has also been named sclerosing pan-
creatitis and idiopathic fibrosing pancreatitis [3,4].
Autoimmune pancreatitis has been described in asso-
ciation with Sjo¨gren syndrome, Crohn’s disease and
ulcerative colitis [5]. Its incidence in Japan is 5.93
patients per 100 000 inhabitants per year, with a
prevalence of 4.78 patients per 100 000 inhabitants
[6]. Sjo¨gren syndrome was associated with 25% of the
cases of autoimmune pancreatitis in a review of 40
institutions in Japan [7]. The second most common
associated disease was primary sclerosing cholangitis
(13%), followed by systemic lupus erithematodes.
In line with the Japanese criteria for the diagnosis of
autoimmune pancreatitis, our patient had obstruc-
tive jaundice secondary to fibrosing pancreatitis, with
a probable autoimmune aetiology associated with
ulcerative colitis. In some patients with Crohn’s
disease and ulcerative colitis, this condition has been
associated with antibodies against pancreatic juice [8].
Other authors have found high serum IgG4 concen-
trations, suggesting an autoimmune pathogenesis [9].
Glucocorticoid therapy induces clinical remission and
would be the first-line treatment [6,9], although many
patients require subsequent operation [3].
Autoimmune pancreatitis should be considered
in young patients with obstructive jaundice [10],
especially those affected with chronic inflammatory
or autoimmune diseases [11].
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Variation of a variation: Case report of attenuated familial
adenomatous polyposis
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Abstract
Background. First described in 1988, attenuated familial adenomatous polyposis (AFAP) is a rare autosomal dominant
precancerous condition of the gastrointestinal tract. Few reports have described adenocarcinomatous change in the
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